Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Licenses Nanopore Technology from Harvard to Develop 'Third Generation' Sequencer

NEW YORK (GenomeWeb News) - Sequenom said yesterday that it has exclusively licensed technology from Harvard University that it will use to develop a nanopore-based sequencing platform that will be faster and cheaper than currently available technologies.
 
The technology, which is able to detect a single strand of DNA as it passes through a nanopore, was developed by Amit Meller, an associate professor at Boston University’s Department of Biomedical Engineering. Meller invented the technology while at Harvard’s Rowland Institute.
 
Sequenom said it expects the technology to enable DNA sequencing, as well as whole-genome genotyping and RNA and epigenetic analysis.
 
Harry Stylli, CEO of Sequenom, said that the proposed system will be “complementary” to the company’s MassArray genotyping platform. "Near term we expect this nanopore technology to deliver large-scale genotyping solutions and long term we believe it has the potential to provide a commercially viable, rapid, sub-thousand dollar human genome sequencing solution," he said.
 
Financial terms of the license agreement include up-front fees, milestone payments, and royalties from product sales. Further details were not provided.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.